Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement

NCT: NCT05261204 · ENROLLING_BY_INVITATION

NCT IDNCT05261204
StatusENROLLING_BY_INVITATION
Start Date2013-01-01
Completion2027-05-31

Brief Summary

The mechanical intervention is treating aortic valve stenosis (AVS) which may be performed using the standard open surgical approach for aortic valve replacement (AVR) or transcatheter aortic valve implantation (TAVI). The key question of this study is to establish the difference in all-cause and cause-specific (cardiac vs noncardiac) mortality, all hospitalizations for heart failure within 24 months of follow-up, left ventricular reverse remodeling after adjustment for death, as assessed by means of the left ventricular end-diastolic volume (LVEDV), in patients who received the TAVI vs the standard surgical procedure for AVS.

Frequently Asked Questions

What is Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement?

Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement is a clinical trial registered under NCT05261204. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT05261204?

The current status of NCT05261204 (Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement) is: ENROLLING_BY_INVITATION.

When did Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement start?

Transcatheter Aortic Valve Implantation Versus Standard Surgical Aortic Valve Replacement started on 2013-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.